The FDA has approved Itvisma (onasemnogene abeparvovec-brve) to treat children two years and older, teens, and adults living with spinal muscular atrophy (SMA). It is indicated for patients with a ...
An autistic child was left without any education or specialist support for nine months after Croydon Council failed to provide the ...
The FDA approved Novartis’ Itvisma (onasemnogene abeparvovec-brve), the company’s first and only gene replacement therapy for spinal muscular atrophy in children 2 and older, as well as for teens and ...
Women who have thyroid dysfunction both before and during pregnancy may have increased risk for having a child diagnosed with ...
Nagoya University researchers and their collaborators have found that minimally invasive laparoscopic surgery significantly ...
This article was reviewed by Darragh O’Carroll, MD. Testosterone Cream: Uses, Side Effects, Dosage, and More Key takeaways: ...
Younger and more diverse teachers reported higher rates of bullying and discrimination by their colleagues. This can also ...
Former "Chrisley Knows Best" star Julie Chrisley weighs in on Ghislaine Maxwell's alleged preferential treatment in federal ...
A national study by University of Adelaide researchers is paving the way for more precise diagnosis and treatment for ...
Autism diagnoses rise not from zebras like Tylenol, but from policy "horses": insurance mandates, Medicaid access, and financial incentives.
Brown County's seven treatment court programs seek to address the root causes leading repeat offenders to crime.
A doctor advising ... sleepaway camp? That's how a 12-year-old diagnosed with lupus found himself laughing on a high-ropes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback